OLFC

PHILADELPHIA - Olfactory Biosciences Corp ( OTC: OLFC) today announced that it has signed a distribution agreement with Lab Consulting LLP, of Kazakhstan. Kazakhstan is the world's ninth largest country in the world and declared itself an independent country onDecember 16, 1991, the last Soviet republic to do so. Lab Consulting LLP will market all of the NOXO™ products and begin with its new and improved, all natural formulation for NOXO Odor Defense™ and other NOXO products. NOXO products contain special proprietary formulations of Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds, designed to have far-reaching applications around the world for people who must endure noxious smells as well those that desire natural wellness products that are non invasive and without side effects. " We are very excited and look forward to working with our new partner, OlfactoryBiosciences, and our Exclusive Distributorship for the NOXO products. We are both fortunate to be on the ground floor with the new NOXO™ products in our country," saidAsset Madiyev, founder and president. NOXO is a gel, applied topically under the nostrils, specifically formulated to block the physical discomfort, retching, nausea and vomiting associated with offensive and unpleasant odors. NOXO's innovation is to control the effects of offensive and unpleasant odors at the olfactory receptor site in the nose, whereas other products attempt to control bad odors at the source.

Uniquely formulated NOXO Odor Defense™ is based on advanced olfactory perception altering technology developed by Dr. V Ruth Pinney who is a director of Olfactory Biosciences Corp and who also conducts the research for the company's products at her research facility in The Woodlands Texas. About Lab Consulting LLP We have been operating since 2007 focusing on sales of laboratory equipment, forensic equipment and chemicals in hospitals, research institutions and the government. The company employs qualified specialists and is partners with well-known companies in Europe, the U.S., China and Japan. We also work with many specialized companies in the CIS. In the U.S., we work with companies such as Quadrex Corporation, Promega , and AccuStandard . Our new partner, Olfactory Biosciences will benefit from our experience in working with law enforcement agencies and forensic laboratories. Website

About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples. This company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique wellness products that are affordable and made from all natural ingredients. Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today. Olfactory Biosciences Corp’s unique advantages will make NOXO products the most sought-after wellness products in the alternative medicine market, creating a growth rate ten times higher than most in the this growing category. INVESTORS

FORWARD-LOOKING STATEMENTS "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding sales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release. Richard Stevenson

Olfactory Biosciences Corp., Inc.
333 E. Lancaster Ave.
Suite 317
Wynnewood, PA 1909
USA
Phone: 484-278-1626

Asset Madiyev
LAB CONSULTING LLP
Almaty, Kazakhstan, 050028
"Kokzhiek" d.26 office 50.
Phones: +7 (727) 3177580

(USOTC:OLFC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

(USOTC:OLFC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024